CRISPR babies still too risky, warns new report

Human embryos whose genomes have been edited should not be used to create a pregnancy until it is certain that changes can be made without introducing undesired changes, according to a new report by an influential panel.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

AstraZeneca to launch CRISPR-based cancer research centre

11 December 2018 Pharmaceutical company AstraZeneca and charity Cancer Research UK have announced that they will launch a centre to accelerate the discovery of new cancer treatments.

Biotechnology

LSPN Connect: CRISPR technologies

21 August 2020 In an LSPN Connect session, Millipore’s senior corporate patent counsel, Ben Sodey, and head of legal and IP at Arbor, Kelly Morgan, shared their insights on the latest developments in this area of gene editing technology.

More on this story

Biotechnology

AstraZeneca to launch CRISPR-based cancer research centre

11 December 2018 Pharmaceutical company AstraZeneca and charity Cancer Research UK have announced that they will launch a centre to accelerate the discovery of new cancer treatments.

Biotechnology

LSPN Connect: CRISPR technologies

More on this story

Biotechnology

AstraZeneca to launch CRISPR-based cancer research centre

11 December 2018 Pharmaceutical company AstraZeneca and charity Cancer Research UK have announced that they will launch a centre to accelerate the discovery of new cancer treatments.

Biotechnology

LSPN Connect: CRISPR technologies